Benoit Pons

Benoit Pons

@benoitjpons.bsky.social

Lecturer in bacterial genomics at Université de Toulouse Research in phage-bacteria co-evolution at LMGM-CBI @cbitoulouse.bsky.social he/him

339 followers258 following18 posts

View full thread
View full thread
View full thread

📢 Registration & abstract submission are open until September 25! 💶 Registration, including the gala dinner: Students/postdocs/fixed-term researchers: FREE Permanent academics: €50 excl. VAT Industry: €300 excl. VAT

The conference will cover 5 major themes, from the molecular scale to societal issues, each of them being introduced by an international speaker: 🔬 Structure & Assembly — Molecular Scale with Marion Schuller @schullerm.bsky.social from Max Planck Institute of Biochemistry 🇩🇪

Benoit Pons reposted

Benoit Pons reposted

If you have a Gmail account, you need to read this. Google's AI now scans your emails and attachments, bank statements, tax files, medical letters, all of it. It turned on by default, and there's a class-action lawsuit over how. Here are 5 moves to shut it off, the switch is hidden in two places:

Benoit Pons reposted

🔬🦠 Comment #Klebsiella parvient-elle à changer de capsule aussi fréquemment pour mieux s’adapter à son environnement ? Les travaux de @julielebris.bsky.social mis à la une par @cnrsbiologie.bsky.social 👏 -avec @epcrocha.bsky.social #MicroSky @cbitoulouse.bsky.social

CNRS Biologie@cnrsbiologie.bsky.social

#ResultatScientifique🔎| Une bactérie capable de changer de « bouclier » pour mieux s’adapter à son environnement : une stratégie étonnante de Klebsiella pneumoniae qui éclaire ses capacités d’évolution et de résistance. ✍️ @olayarendueles.bsky.social @julielebris.bsky.social ▶️ buff.ly/q8AKHo1

Benoit Pons reposted

So happy to see this finally published in @plosbiology.org! This is the first chapter of @julielebris.bsky.social PhD thesis demonstrating how capsules are exchanged by plug-and-play dynamics w/ @epcrocha.bsky.social #microsky @klebclub.bsky.social Link below- Check out her 🧵 for more details!

doi.orgPlug-and-play evolution of the Klebsiella pneumoniae capsule locus enables serotype exchange across genetic backgroundsHow complex multi-gene systems evolve across genetic backgrounds without disruptive epistasis remains unclear, particularly in highly exchangeable loci such as the capsule of Klebsiella pneumoniae. Th...
Julie Le Bris@julielebris.bsky.social

How complex functions, with important physiological and evolutionary impacts get repeatedly and efficiently transferred across genomes? That’s what we explored using one of the fastest-evolving loci in Bacteria: the capsule locus. The paper: www.biorxiv.org/content/10.1... Thread👇

Benoit Pons reposted

Preprint alert📢! 
Ever wondered how much bacterial parasites influence evolutionary outcomes of their host? ➡️ We co-evolved two bacterial strains in conditions in which the costs and benefits of prophage carriage varied Here is what we found. 
www.biorxiv.org/content/10.6... 
#MicroSky #PhageSky 🧵

biorxiv.orgEnvironment-dependent evolution drives divergent adaptive strategies and parasite dynamics in a minimal communityProphages, phage genomes integrated into bacterial chromosomes, are widespread, yet, the extent to which these resident parasites contribute to host fitness and shape evolutionary trajectories, partic...

Overall, we conclude that while CRISPR-immunity prevents bacteria from dying at high phage doses, a subpopulation undergoes SOS-response mediated growth defects and elongation. Conversely, surface-based resistant bacteria do not, thus favouring this type of resistance at high phage dose.

We then tested our second hypothesis, that CRISPR-immune bacteria were displayed growth defects compared to surface-based resistant bacteria at high phage doses. We did not observe a significant difference in growth rate at the whole population level.

However, we noticed some heterogeneity in the population, with some CRISPR-immune bacteria stalling and suffering from elongation, particularly at high phage doses, which is consistent with this second hypothesis

While CRISPR-Cas system inability to fully prevent phage gene expression seemed to play a role, it was still unclear what was causing the apparent CRISPR-Cas fitness cost at high phage doses. Here we investigated two hypotheses by using a microfluidics set-up to follow single bacteria in microscopy.

Our first hypothesis was that at high phage dose, surface-based resistance offered more protection than CRISPR-immunity. However, we showed that both types of defences offer a similar, almost perfect protection against phages regardless of the phage dose.

Pseudomonas aeruginosa can choose between CRISPR-Cas immunity and resistance through surface receptor mutation to evade their phages foes. Previous work from the lab had shown that the choice depends on the strength of phage selection pressure, with CRISPR-immunity being favoured at low phage dose.

Benoit Pons reposted

Benoit Pons reposted

Benoit Pons reposted

Had an amazing time at @cbitoulouse.bsky.social! Stimulating discussions, insightful questions, and always a joy to reconnect with old friends and colleagues! Thanks for the invitation @benoitjpons.bsky.social @olayarendueles.bsky.social

Olaya Rendueles@olayarendueles.bsky.social

Great talk today @cbitoulouse.bsky.social from @annechevallereau.bsky.social- on the importance of surface receptors in phage adsorption and of intracellular phage defense mechanisms - and the relative importance of each of them in shaping phage host range &productive phage infection 🦠

Benoit Pons reposted

Just out in The ISME Journal, a paper from my time in the Westra lab. We find that the extent of phage exposure shapes subsequent resistance dynamics over longer timescales (up to 30 days). And huge thanks to first authors @bridgetwatson.bsky.social and Loris for mammoth experiments!

Ákos T Kovács@evolvedbiofilm.bsky.social

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures ISME Journal by Bridget Watson et al with @ellinoralseth.bsky.social @seanmeaden.bsky.social academic.oup.com/ismej/advanc...

You are up to date.